Nektar Therapeutics (NKTR)

P/S ratio as of March 2025 (TTM): 1.66

According to Nektar Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.16. At the end of 2024 the company had a P/S ratio of 2.31.

P/S ratio history for Nektar Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	2.31	93.35%
2023	1.20	-74.08%
2022	4.61	-81.14%
2021	24.5	22.68%
2020	19.9	-40%
2019	33.2	595.41%
2018	4.78	-84.36%
2017	30.6	169.61%
2016	11.3	14.76%
2015	9.88	-2.52%
2014	10.1	14.13%
2013	8.88	-15.6%
2012	10.5	17.45%
2011	8.96	17.28%
2010	7.64	-36.81%
2009	12.1	112.06%
2008	5.70	151.25%
2007	2.27	-64.43%
2006	6.38	-44.22%
2005	11.4	-23.68%
2004	15.0	108.11%
2003	7.20	52.09%
2002	4.73	-64.13%
2001	13.2

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Amgen AMGN	5.04	203.88%	🇺🇸 USA
Pfizer PFE	2.42	45.68%	🇺🇸 USA
Merck MRK	3.79	128.69%	🇺🇸 USA
Richardson Electronics RELL	0.8746	-47.27%	🇺🇸 USA
AstraZeneca AZN	4.39	164.44%	🇬🇧 UK
Baxter BAX	1.27	-23.54%	🇺🇸 USA
Alkermes ALKS	3.51	111.73%	🇮🇪 Ireland
Johnson & Johnson JNJ	4.42	166.71%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Nektar Therapeutics (NKTR)

P/S ratio as of March 2025 (TTM): 1.66